MHC class I molecules and KIRs in human history, health and survival

被引:929
作者
Parham, P [1 ]
机构
[1] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nri1570
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC class I molecules are ligands for the killer-cell immunoglobulin-like receptors (KIRs), which are expressed by natural killer cells and T cells. The interactions between these molecules contribute to both innate and adaptive immunity. KIRs and MHC class I molecules are encoded by unlinked polymorphic gene families that distinguish all but the most related individuals. Combinations of MHC class I and KIR variants influence resistance to infections, susceptibility to autoimmune diseases and complications of pregnancy, as well as outcome after haematopoietic stem-cell transplantation. Such correlations raise the possibility that interplay between KIR and MHC class I polymorphisms has facilitated human survival in the presence of epidemic infections and has influenced both reproduction and population growth.
引用
收藏
页码:201 / 214
页数:14
相关论文
共 125 条
[11]   The LILR family: modulators of innate and adaptive immune pathways in health and disease [J].
Brown, D ;
Trowsdale, J ;
Allen, R .
TISSUE ANTIGENS, 2004, 64 (03) :215-225
[12]   NK3-SPECIFIC NATURAL-KILLER-CELLS ARE SELECTIVELY INHIBITED BY BW4-POSITIVE HLA ALLELES WITH ISOLEUCINE-80 [J].
CELLA, M ;
LONGO, A ;
FERRARA, GB ;
STROMINGER, JL ;
COLONNA, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1235-1242
[13]   DNA methylation maintains allele-specific KTR gene expression in human natural killer cells [J].
Chan, HW ;
Kurago, ZB ;
Stewart, CA ;
Wilson, MJ ;
Martin, MP ;
Mace, BE ;
Carrington, M ;
Trowsdale, J ;
Lutz, CT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :245-255
[14]   Recognition by gamma/delta T cells [J].
Chien, YH ;
Jores, R ;
Crowley, MP .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :511-532
[15]   HLA-C IS THE INHIBITORY LIGAND THAT DETERMINES DOMINANT RESISTANCE TO LYSIS BY NK1-SPECIFIC AND NK2-SPECIFIC NATURAL-KILLER-CELLS [J].
COLONNA, M ;
BORSELLINO, G ;
FALCO, M ;
FERRARA, GB ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :12000-12004
[16]   The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia [J].
Cook, MA ;
Milligan, DW ;
Fegan, CD ;
Darbyshire, PJ ;
Mahendra, P ;
Craddock, CF ;
Moss, PAH ;
Briggs, DC .
BLOOD, 2004, 103 (04) :1521-1526
[17]   Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants [J].
Davies, SM ;
Ruggieri, L ;
DeFor, T ;
Wagner, JE ;
Weisdorf, DJ ;
Miller, JS ;
Velardi, A ;
Blazar, BR .
BLOOD, 2002, 100 (10) :3825-3827
[18]   Genetic divergence of the rhesus macaque major histocompatibility complex [J].
Daza-Vamenta, R ;
Glusman, G ;
Rowen, L ;
Guthrie, B ;
Geraghty, DE .
GENOME RESEARCH, 2004, 14 (08) :1501-+
[19]   Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation [J].
Dupont, B ;
Hsu, KC .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (05) :634-643
[20]   Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes [J].
Epling-Burnette, PK ;
Painter, JS ;
Chaurasia, P ;
Bai, FQ ;
Wei, S ;
Djeu, JY ;
Loughran, TP .
BLOOD, 2004, 103 (09) :3431-3439